1155 DIETARY CHOLESTEROL PROMOTES SHIFTS IN LIVER MICROBIOTA COMMUNITY MEMBERSHIP AND DRIVES HEPATIC CD8+ T-CELL EXHAUSTION IN A MOUSE MODEL OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Leggi →
Maggio 2024
Risultati per: Microbiota e steatosi epatica: quali evidenze?
Questo è quello che abbiamo trovato per te
576 MICROBIOTA-INDUCED S100A11-RAGE AXIS UNDERLIES IMMUNOEVASION IN RIGHT-SIDED COLON ADENOMAS AND IS A THERAPEUTIC TARGET TO BOOST ANTI-PD1 EFFICACY
Leggi →
Maggio 2024
Sa1851 THE EFFECT OF DYSBIOTIC GUT MICROBIOTA IN FAMILIES WITH PEDIATRIC IBD ON INTESTINAL INFLAMMATION IN HUMANIZED GNOTOBIOTIC TL1A TRANSGENIC MICE
Leggi →
Maggio 2024
733 FECAL MICROBIOTA TRANSPLANTATION DOES NOT AFFECT THE RESISTOMES OF PATIENTS WITH CHRONIC POUCHITIS
Leggi →
Maggio 2024
957 A RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFECT OF ENVIRONMENTAL RICHNESS ON GASTROINTESTINAL SYMPTOMS, SALIVARY CORTISOL, AND GUT MICROBIOTA IN EARLY CHILDHOOD
Leggi →
Maggio 2024
913 THE BILE ACIDS METABOLITES PRODUCED BY THE INTESTINAL MICROBIOTA ACT AS GPBAR1 AGONIST AND RORΓT INVERSE AGONIST DETERMINING THE COURSE OF INFLAMMATORY BOWEL DISEASE
Leggi →
Maggio 2024
533 REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST
Leggi →
Maggio 2024
693 ACUTE CENTRAL STRESS DAMAGE THE COLONOCYTE MITOCHONDRIA AND DISTURB MICROBIOTA COMMUNITY VIA CRHR1
Leggi →
Maggio 2024
625 MUCOSAL ENTERIC GLIA RELEASE CILIARY NEUROTROPHIC FACTOR (CNTF) TO MAINTAIN THE HOMEOSTASIS OF ENTERIC NEURAL CIRCUITS BY AN INDIGENOUS GUT-MICROBIOTA DRIVEN CONSTITUTIVE MECHANISM
Leggi →
Maggio 2024
494 ORAL SODIUM BUTYRATE ADMINISTRATION SIGNIFICANTLY IMPROVES CLINICAL OUTCOME AND QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE BY MODIFYING THE GUT MICROBIOTA – RESULTS FROM A RANDOMISED PLACEBO-CONTROLLED STUDY
Leggi →
Maggio 2024
400 VITAMIN D DIFFERENTIALLY REGULATES MUCOSAL IMMUNOGLOBULIN BINDING TO GUT MICROBIOTA AND DENDRITIC CELL-B CELL SIGNALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Leggi →
Maggio 2024
731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY
Leggi →
Maggio 2024
715 THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
Leggi →
Maggio 2024
Sa1527 RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION IS CHARACTERIZED BY A DISTINCT GUT MICROBIOTA PROFILE
Leggi →
Maggio 2024
Tu1921 EVALUATION OF INTESTINAL MICROBIOTA COMPOSITION PRE- AND POST ENDOSCOPIC SLEEVE GASTROPLASTY: A PROSPECTIVE OBSERVATIONAL COHORT STUDY
Leggi →
Maggio 2024
Tu1916 LABTHERA-002, A LIVE BIOTHERAPEUTIC PRODUCT, IMPROVES THE FOLFOX-INDUCED CACHEXIA IN COLORECTAL CANCER MICE MODEL THROUGH GUT MICROBIOTA MODULATION.
Leggi →
Maggio 2024
